T28	Measurement 1633 1648	PaO2/FiO2 ratio
T31	Subject 1730 1738;1756 1762	survivor groups
T33	Subject 809 820	36 patients
T38	Subject 933 944	41 patients
T44	Subject 2003 2011	patients
T45	Disorder 341 376	acute respiratory distress syndrome
T50	Subject 717 728	77 patients
T51	Subject 1747 1755;1756 1762	survivor groups
T56	Pharmacological_substance 1100 1124	immunosuppressive agents
T69	Disorder 2027 2052	acute respiratory failure
T76	Artificial_process 646 668	conventional treatment
T77	Subject 575 583	patients
T83	Disorder 546 571	acute respiratory failure
T89	Disorder 323 329	sepsis
E13	Artificial_process:T76 Theme:T58
N104	Reference T28 UMLS:C3897988	Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement
N112	Reference T31 UMLS:C0206194	Survivors
N118	Reference T33 UMLS:C0030705	Patients
N137	Reference T38 UMLS:C0030705	Patients
N160	Reference T44 UMLS:C0030705	Patients
N190	Reference T50 UMLS:C0030705	Patients
N192	Reference T51 UMLS:C0206194	Survivors
N205	Reference T56 UMLS:C0021081	Immunosuppressive Agents
N255	Reference T69 UMLS:C0264490	Acute respiratory failure
N274	Reference E13 UMLS:C2945704	Conventional Treatment
N275	Reference T77 UMLS:C0030705	Patients
N300	Reference T83 UMLS:C0264490	Acute respiratory failure
N328	Reference T89 UMLS:C0243026	Sepsis
N3	Reference T45 UMLS:C0748355	Acute respiratory distress
T93	Disorder 89 132	rapidly progressive interstitial pneumonias
N5	Reference T93 UMLS:C0206061	Pneumonia, Interstitial
T94	Disorder 405 448	rapidly progressive interstitial pneumonias
N6	Reference T94 UMLS:C0206061	Pneumonia, Interstitial
T95	Disorder 450 455	RPIPs
N8	Reference T95 UMLS:C0206061	Pneumonia, Interstitial
T96	Disorder 589 594	RPIPs
N9	Reference T96 UMLS:C0206061	Pneumonia, Interstitial
T97	Disorder 734 739	RPIPs
N10	Reference T97 UMLS:C0206061	Pneumonia, Interstitial
T98	Disorder 1997 2002	RPIPs
N12	Reference T98 UMLS:C0206061	Pneumonia, Interstitial
T21	Pharmacological_substance 1077 1092	corticosteroids
N14	Reference T21 UMLS:C0001617	Adrenal Cortex Hormones
T52	Artificial_process 530 541	DHP therapy
E18	Artificial_process:T52 
N22	Reference E18 UMLS:C0019063	Hemoperfusion
T61	Artificial_process 1442 1453	DHP therapy
E11	Artificial_process:T61 
N28	Reference E11 UMLS:C0019063	Hemoperfusion
T82	Artificial_process 1965 1976	DHP therapy
E19	Artificial_process:T82 
N30	Reference E19 UMLS:C0019063	Hemoperfusion
T11	Artificial_process 682 685	DHP
E4	Artificial_process:T11 
N31	Reference E4 UMLS:C0019063	Hemoperfusion
T86	Artificial_process 883 886	DHP
E16	Artificial_process:T86 
N32	Reference E16 UMLS:C0019063	Hemoperfusion
T88	Artificial_process 1004 1007	DHP
E20	Artificial_process:T88 
N33	Reference E20 UMLS:C0019063	Hemoperfusion
T91	Artificial_process 1013 1016	DHP
E21	Artificial_process:T91 
N36	Reference E21 UMLS:C0019063	Hemoperfusion
T99	Artificial_process 1374 1377	DHP
E22	Artificial_process:T99 
N37	Reference E22 UMLS:C0019063	Hemoperfusion
T100	Artificial_process 1714 1717	DHP
E23	Artificial_process:T100 
N38	Reference E23 UMLS:C0019063	Hemoperfusion
T58	Subject 617 635	historical control
N40	Reference T58 UMLS:C2986415	Historical Control Subject
T64	Subject 1017 1022	group
N41	Reference T64 UMLS:C1257890	Population Group
T85	Subject 1194 1200	groups
N42	Reference T85 UMLS:C1257890	Population Group
T102	Subject 1378 1383	group
N43	Reference T102 UMLS:C1257890	Population Group
T112	Subject 1396 1404	controls
N46	Reference T112 UMLS:C0009932	Control Groups
T1	Subject 888 913	historical control group)
N1	Reference T1 UMLS:C2986415	Historical Control Subject
R1	Subject_Disorder Arg1:T77 Arg2:T96	
R2	Subject_Disorder Arg1:T50 Arg2:T97	
R3	Subject_Disorder Arg1:T44 Arg2:T98	
T14	Negative_regulation 2072 2078	reduce
E1	Negative_regulation:T14 Cause:E36 Cue:T9
N4	Reference E1 UMLS:C3463820	Inhibition
T37	Measurement 1829 1844	PaO2/FiO2 ratio
N24	Reference T37 UMLS:C3897988	Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement
R5	Disorder_association Arg1:T89 Arg2:T45	
T8	Measurement 1904 1921	neutrophil counts
N2	Reference T8 UMLS:C0200633	Neutrophil count (procedure)
T17	Anatomical_entity 1898 1903	blood
N18	Reference T17 UMLS:C0005767	Blood
T39	Anatomical_entity 1666 1671	blood
N23	Reference T39 UMLS:C0005767	Blood
T41	Measurement 1672 1689	neutrophil counts
N25	Reference T41 UMLS:C0200633	Neutrophil count (procedure)
T7	Correlation 2012 2023	accompanied
E2	Correlation:T7 Theme:T98 Theme2:T69
N16	Reference E2 UMLS:C0332281	Associated with
T10	Correlation 1868 1878	correlated
E3	Correlation:T10 Theme:T37 Theme2:E25
N21	Reference E3 UMLS:C0332281	Associated with
T12	Artificial_process 863 870	treated
E5	Artificial_process:T12 Theme:T33 Instrument:E17 Cue:T42
N26	Reference E5 UMLS:C0087111	Therapeutic procedure
T16	Artificial_process 987 994	treated
E6	Artificial_process:T16 Theme:T38 Instrument:E31
N29	Reference E6 UMLS:C0087111	Therapeutic procedure
E8	Artificial_process:T12 Instrument:T56 Theme:T33
N48	Reference E8 UMLS:C0087111	Therapeutic procedure
E10	Artificial_process:T12 Instrument:T21 Theme:T33
N49	Reference E10 UMLS:C0087111	Therapeutic procedure
E15	Artificial_process:T16 Instrument:T56 Theme:T38
N50	Reference E15 UMLS:C0087111	Therapeutic procedure
E24	Artificial_process:T16 Instrument:T21 Theme:T38
N51	Reference E24 UMLS:C0087111	Therapeutic procedure
T42	Negation_cue 871 878	without
T43	Regulation 1888 1894	change
E25	Regulation:T43 Theme:T8
N55	Reference E25 UMLS:C1327622	Regulation of biological process
T46	Entity_Property 405 424	rapidly progressive
N54	Reference T46 UMLS:C0205329	Progressive
T48	Disorder 425 448	interstitial pneumonias
N56	Reference T48 UMLS:C0206061	Pneumonia, Interstitial
R6	member_of Arg1:T94 Arg2:T48	
T54	Disorder 109 132	interstitial pneumonias
N57	Reference T54 UMLS:C0206061	Pneumonia, Interstitial
T55	Entity_Property 89 108	rapidly progressive
N58	Reference T55 UMLS:C0205329	Progressive
R7	member_of Arg1:T93 Arg2:T54	
R8	Subject_Disorder Arg1:T77 Arg2:T83	
T66	Artificial_process 526 541	PMX-DHP therapy
E29	Artificial_process:T66 Theme:T77
T71	Artificial_process 678 685	PMX-DHP
E30	Artificial_process:T71 Theme:T58 Cue:T3
T72	Artificial_process 1000 1007	PMX-DHP
E31	Artificial_process:T72 
T74	Artificial_process 1009 1016	PMX-DHP
E32	Artificial_process:T74 Theme:T64
T78	Artificial_process 1370 1377	PMX-DHP
E33	Artificial_process:T78 Theme:T102
T79	Artificial_process 1438 1453	PMX-DHP therapy
E34	Artificial_process:T79 
T87	Artificial_process 1710 1717	PMX-DHP
E35	Artificial_process:T87 Theme:T31 Theme2:T51
T92	Artificial_process 1961 1976	PMX-DHP therapy
E36	Artificial_process:T92 
R12	member_of Arg1:E29 Arg2:E18	
R13	member_of Arg1:E30 Arg2:E4	
T3	Negation_cue 669 676	without
T5	Artificial_process 879 886	PMX-DHP
E17	Artificial_process:T5 
R14	member_of Arg1:E17 Arg2:E16	
A2	Negated E30
R15	member_of Arg1:E31 Arg2:E20	
R16	member_of Arg1:E32 Arg2:E21	
R17	member_of Arg1:E34 Arg2:E11	
R18	member_of Arg1:E36 Arg2:E19	
A1	Negated E5
T9	Speculation_cue 2060 2068	expected
A3	Speculated E1
T23	Regulation 1984 1993	effective
E27	Regulation:T23 Cue:T20 Theme:T98 Cause:E36
N11	Reference E27 UMLS:C1327622	Regulation of biological process
T20	Speculation_cue 1977 1980	may
A4	Speculated E27
R19	member_of Arg1:E35 Arg2:E23	
R20	member_of Arg1:E33 Arg2:E22	
T47	Artificial_process 12 75	direct hemoperfusion using polymyxin B-immobilized fiber column
E7	Artificial_process:T47 
T53	Artificial_process 77 84	PMX-DHP
E9	Artificial_process:T53 
T59	Artificial_process 219 300	Direct hemoperfusion using polymyxin B-immobilized fiber column (PMX-DHP) therapy
E12	Artificial_process:T59 
T60	Artificial_process 12 32	direct hemoperfusion
E14	Artificial_process:T60 
N15	Reference E14 UMLS:C0019063	Hemoperfusion
T80	Artificial_process 81 84	DHP
E26	Artificial_process:T80 
N45	Reference E26 UMLS:C0019063	Hemoperfusion
T103	Artificial_process 219 239	Direct hemoperfusion
E28	Artificial_process:T103 
N59	Reference E28 UMLS:C0019063	Hemoperfusion
R9	member_of Arg1:E7 Arg2:E14	
R10	member_of Arg1:E9 Arg2:E26	
R11	member_of Arg1:E12 Arg2:E28	
